Status and phase
Conditions
Treatments
About
This study is designated to evaluate the pharmacokinetic interactions of bisoprolol and rosuvastatin in healthy male volunteers.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subjects with a history of gastrointestinal diseases which might significantly change ADME(Absorption, Distribution, Metabolism and Excretion) of medicines
History of clinically significant arrhythmic, peripheral vascular,thyroid, bronchospasm, asthma disease
Subjects with anaphylaxis to bisoprolol and/or rosuvastatin
History of drug abuse
History of caffeine, alcohol, smoking abuse
Clinical laboratory test values are outside the accepted normal range
Subjects with whole blood donation within 60days, component blood donation within 30days and blood transfusion within 30days prior to study medication dosing
Subjects considered as unsuitable based on medical judgement by investigators
Primary purpose
Allocation
Interventional model
Masking
0 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal